呼吸治療機器のグローバル市場予測(~2028):治療薬、パルスオキシメーター、スパイロメーター

【英語タイトル】Respiratory Care Devices Market by Product (Therapeutic (CPAP, Ventilator, Nebulizer, Inhaler), Pulse Oximeter, Spirometer), Indication, End User, Key stakeholders & Expectations, Unmet needs, Buying Criteria, Reimbursement - Global Forecast to 2028

MarketsandMarketsが出版した調査資料(MD1583-23)・商品コード:MD1583-23
・発行会社(調査会社):MarketsandMarkets
・発行日:2023年9月26日
・ページ数:449
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後24時間以内)
・調査対象地域:グローバル
・産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧)USD4,950 ⇒換算¥732,600見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥984,200見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥1,206,200見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・送付(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
❖ レポートの概要 ❖

"世界の呼吸治療機器市場は、年平均成長率7.8%で、2023年の218億米ドルから2028年には318億米ドルに達すると予測" 世界的な老人人口の急速な増加による呼吸器疾患の有病率の上昇が市場成長の原動力となるでしょう。

"COPDと喘息は世界中で最も流行している呼吸器疾患である"
WHOによると、COPDは世界第3位の死因であり、2019年には320万人が死亡しています。このうち80%以上が中低所得国で発生しています。世界では3億8,000万人以上がCOPDに罹患していると予想されています。中国、インド、ブラジル、東欧などの地域や国では、未診断のCOPD患者が多くなっています。COPDのために医療制度にかかる費用は、世界中で年間500億ドル近くに上ります。COPDの主な原因としては、長期喘息、タバコの煙への長期暴露、屋内外の大気汚染、職業上の煙や粉塵などが挙げられます。COPDには、心血管疾患、筋骨格系障害、糖尿病などの慢性疾患が併存しています。これらの疾患は患者の健康状態に影響を与えるだけでなく、COPDの管理にも支障をきたす可能性があります。

"人工呼吸器セグメントが呼吸治療機器市場の主要シェアを占める"
呼吸治療機器市場は、人工呼吸器、気道陽圧(PAP)機器、加湿器、ネブライザー、酸素濃縮器、再利用可能な蘇生器、吸入器、マスク、一酸化窒素送達ユニット、酸素フードに区分されます。2022年、呼吸治療機器市場で大きなシェアを占めるのは人工呼吸器分野です。人工呼吸器セグメントの大きなシェアは、人工呼吸器を備えた集中治療ベッド数の増加、先進国におけるICU入室と再入室の増加、有利な償還シナリオに起因しています。

"COPD分野が呼吸治療機器市場の主要シェアを占める"
疾患別では、呼吸治療機器市場は慢性閉塞性肺疾患(COPD)、喘息、睡眠時無呼吸症候群、感染症、その他の疾患適応症に区分されます。呼吸治療機器市場で大きなシェアを占めるのはCOPD分野です。COPDセグメントの大きなシェアは、タバコ喫煙、遺伝的疾患、高齢者人口の増加によるものです。COPDの有病率の高さとCOPDによる死亡者数の増加が、予測期間中の呼吸治療機器の需要を促進すると予測されています。

"病院セグメントが呼吸治療機器市場の主要シェアを占める"
エンドユーザー別に見ると、呼吸治療機器市場は病院、在宅ケア環境、外来ケアセンター(ACC)、その他のエンドユーザーに区分されます。呼吸治療機器市場で大きなシェアを占めるのは病院部門です。病院セグメントの大きなシェアは、高価な機器を購入するための病院の財政能力と、呼吸治療機器を操作するための訓練を受けた専門家が病院にいることに起因しています。また、景気拡大傾向や、政府がより広範な福祉政策に力を入れていることも、新興国の医療セクターの成長につながりました。

"アジア太平洋地域は予測期間中最高のCAGRで成長"
2022年、アジア太平洋地域は予測期間中に最高のCAGRで成長するでしょう。この市場の高成長の主な要因は、日本、中国、インド、韓国、台湾、オーストラリア、シンガポールなどの高成長市場にあります。これらの国々では、高齢者人口の増加、一人当たり所得の増加、主要市場プレイヤーによるヘルスケア産業への投資の増加が見られます。

"収益性と機動性の向上、遠隔監視の強化-呼吸治療機器市場におけるアンメットニーズ"
呼吸器患者の多くは酸素療法を必要としていますが、機動性を高めるため、より軽量でコンパクトな機器を必要としています。現在入手可能なポータブル機器は、このニーズを十分に満たしていない可能性があります。入院を減らし、患者の転帰を改善するために、患者の遠隔モニタリングに対する需要が高まっています。しかし、既存のソリューションでは、完全な統合やリアルタイムのデータ伝送が不十分な場合があります。

呼吸治療機器市場(供給側)の主要参入企業のプロファイルの内訳:
- 企業タイプ別:ティア1:35%、ティア2:40%、ティア3:25%
- 役職別 Cレベル:20%、ディレクターレベル:35%、その他:45%
- 地域別 北米30%、欧州27%、アジア太平洋25%、中東10%、中南米8%

呼吸治療機器市場における主要参入企業のプロフィール(需要側)
- エンドユーザー別:病院47%、在宅ケア33%、その他20%
- 職業別 医師-35%、診断センターラボ責任者-27%、病院長・管理者-22%、その他-16%
- 地域別 北米-34%、欧州-22%、アジア太平洋地域-20%、中南米-16%、中東・アフリカ-8%

呼吸治療機器市場の主なプレーヤーとしては、Koninklijke Philips N.V. (Netherlands), General Electric Healthcare (US), ResMed Inc. (US), Fisher & Paykel Healthcare Corporation Limited (New Zealand), Medtronic plc (Ireland), Masimo Corporation (US), Drägerwerk AG & Co.(Germany), Getinge AB (Sweden), Nihon Kohden Corporation (US), Vyaire Medical (US), Hill-Rom, Inc. (US), AdaptHealth LLC (US), Rotech Healthcare, Inc. (US), Teleflex Incorporated(Japan), Air Liquide (France), Invacare Corporation (US), ICU Medical Inc. (US), Hamilton Medical AG (Switzerland), Apex Medical Corporation (Taiwan), Apex Medical Corporation (US), HUM GmbH (Germany), Nonin Medical (US), Allied Healthcare Products, Inc. (US), Drive DeVilbiss Healthcare (US), OMRON Healthcare, Inc. (Japan)などがあります。

調査範囲
当レポートでは、呼吸治療機器市場を分析し、製品、適応疾患、エンドユーザー、地域などの様々なセグメントに基づいて、市場規模や今後の成長可能性を推計することを目的としています。また、市場で入手可能な様々な呼吸治療機器の製品ポートフォリオマトリックスも掲載しています。また、同市場における主要企業の競合分析も行っており、企業プロフィール、製品、主要市場戦略などを掲載しています。

レポート購入の理由
本レポートは、呼吸治療機器市場全体およびサブセグメントの収益数の最も近い近似値に関する情報を提供し、本市場の市場リーダー/新規参入者に役立ちます。本レポートは、利害関係者が競争状況を理解し、より多くの洞察を得ることで、事業の位置づけを高め、適切な市場参入戦略を計画するのに役立ちます。また、市場の脈動を理解し、主要な市場促進要因、阻害要因、課題、機会に関する情報を提供します。

本レポートは、以下のポイントに関する洞察を提供します:
- 主な促進要因(呼吸器疾患の有病率の上昇、早産発生率の上昇、呼吸器系に影響を及ぼす感染症の発生、睡眠およびCOPDの未開拓市場、患者の転帰改善への注力、技術的に高度なデバイスをもたらす研究開発投資の増加)、阻害要因(不利な償還シナリオ、)、機会(在宅ケア治療機器に対する需要の高まり、発展途上国における高い成長、ポイントオブケア診断、未治療の睡眠時無呼吸症候群の悪影響に対する意識の高まり)、課題(認知度が低く、未診断・未治療の人口が多い、特定の機器が新生児に及ぼす有害な影響)などを分析しています。
- 製品開発/イノベーション:呼吸治療機器市場における今後の技術、研究開発活動、新製品発売に関する詳細な洞察を提供します。
- 市場開発:製品別、適応疾患別、エンドユーザー別、地域別の有利な新興市場に関する包括的情報を提供します。
- 市場の多様化:世界の呼吸治療機器市場における新製品や製品の強化、成長地域、最近の開発、投資に関する詳細な情報を提供します。
- 競合評価:世界の呼吸治療機器市場におけるKoninklijke Philips N.V. (Netherlands), General Electric Healthcare (US), ResMed Inc. (US), Fisher & Paykel Healthcare Corporation Limited (New Zealand), and Medtronic plc (Ireland)などの主要企業の市場シェア、成長戦略、製品提供、競合リーダーシップマッピング、能力を詳細に評価しています。

1 イントロダクション
2 調査方法
3 エグゼクティブサマリー
4 プレミアムインサイト
5 市場概要
6 呼吸治療機器の世界市場:製品別
7 呼吸治療機器の世界市場:疾患別
8 呼吸治療機器の世界市場:エンドユーザー別
9 呼吸治療機器の世界市場:地域別
10 競争状況
11 企業情報
12 付録

❖ レポートの目次 ❖

1 INTRODUCTION 55
1.1 STUDY OBJECTIVES 55
1.2 MARKET DEFINITION 55
1.2.1 INCLUSIONS AND EXCLUSIONS 55
1.3 MARKET SCOPE 56
1.3.1 MARKETS COVERED 56
FIGURE 1 RESPIRATORY CARE DEVICES MARKET SEGMENTATION 56
FIGURE 2 RESPIRATORY CARE DEVICES MARKET, BY REGION 57
1.3.2 YEARS CONSIDERED 57
1.4 CURRENCY CONSIDERED 58
TABLE 1 ANNUAL AVERAGE EXCHANGE RATE FOR CURRENCY CONVERSION, 2018–2022 58
1.5 STAKEHOLDERS 58
1.6 LIMITATIONS 58
1.7 SUMMARY OF CHANGES 58
1.8 RECESSION IMPACT 59
2 RESEARCH METHODOLOGY 60
2.1 RESEARCH DATA 60
FIGURE 3 RESEARCH DESIGN 60
2.1.1 SECONDARY DATA 61
2.1.1.1 Key data from secondary sources 62
2.1.2 PRIMARY DATA 62
FIGURE 4 PRIMARY SOURCES 63
2.1.2.1 Key data from primary sources 64
2.1.2.2 Key industry insights 64
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS 65
FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION 65
FIGURE 7 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER, DESIGNATION, AND REGION 66
2.2 MARKET SIZE ESTIMATION 66
FIGURE 8 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 67
FIGURE 9 REVENUE SHARE ANALYSIS ILLUSTRATION: KONINKLIJKE PHILIPS N.V. 67
FIGURE 10 SUPPLY-SIDE MARKET ESTIMATION: RESPIRATORY CARE DEVICES MARKET (2022) 68
FIGURE 11 DEMAND-SIDE MARKET ESTIMATION: VENTILATORS MARKET (2022) 69
FIGURE 12 TOTAL MARKET SIZE ESTIMATION: RESPIRATORY CARE DEVICES MARKET 70
FIGURE 13 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2023–2028) 71
FIGURE 14 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 72
FIGURE 15 TOP-DOWN APPROACH 73
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 73
FIGURE 16 MARKET DATA TRIANGULATION METHODOLOGY 73
2.4 STUDY ASSUMPTIONS 74
2.4.1 MARKET SHARE ASSUMPTIONS 74
2.4.2 RESEARCH ASSUMPTIONS 74
2.5 RISK ASSESSMENT 74
TABLE 2 RESPIRATORY CARE DEVICES MARKET: RISK ASSESSMENT ANALYSIS 74
2.6 RESEARCH LIMITATIONS 74
2.7 RECESSION IMPACT ANALYSIS 75
3 EXECUTIVE SUMMARY 76
FIGURE 17 RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2023 VS. 2028 (USD MILLION) 76
FIGURE 18 RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2023 VS. 2028 (USD MILLION) 77
FIGURE 19 RESPIRATORY CARE DEVICES MARKET, BY END USER, 2023 VS. 2028 (USD MILLION) 78
FIGURE 20 RESPIRATORY CARE DEVICES MARKET: GEOGRAPHICAL SNAPSHOT 79
4 PREMIUM INSIGHTS 80
4.1 RESPIRATORY CARE DEVICES MARKET OVERVIEW 80
FIGURE 21 HIGH TOBACCO CONSUMPTION TO BOOST MARKET GROWTH THROUGHOUT FORECAST PERIOD 80
4.2 NORTH AMERICA: RESPIRATORY CARE DEVICES MARKET, BY TYPE (2022) 81
FIGURE 22 THERAPEUTIC RESPIRATORY CARE DEVICES ACCOUNTED FOR LARGEST MARKET SHARE IN 2022 81
4.3 RESPIRATORY CARE DEVICES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 82
FIGURE 23 INDIA TO DISPLAY HIGHEST CAGR DURING FORECAST PERIOD 82
4.4 RESPIRATORY CARE DEVICES MARKET: REGIONAL MIX 82
FIGURE 24 NORTH AMERICA TO CONTINUE TO DOMINATE MARKET THROUGHOUT FORECAST PERIOD 82
4.5 RESPIRATORY CARE DEVICES MARKET: DEVELOPED VS. EMERGING ECONOMIES 83
FIGURE 25 EMERGING ECONOMIES TO REGISTER HIGHER CAGRS DURING FORECAST PERIOD 83
5 MARKET OVERVIEW 84
5.1 INTRODUCTION 84
5.2 MARKET DYNAMICS 84
FIGURE 26 RESPIRATORY CARE DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES 84
5.2.1 DRIVERS 85
5.2.1.1 Rising prevalence of respiratory diseases 85
5.2.1.1.1 Rapid growth in global geriatric population 86
FIGURE 27 GLOBAL GERIATRIC POPULATION, BY REGION 86
5.2.1.1.2 Urbanization and growing pollution levels 86
FIGURE 28 ANNUAL DATA OF DEATHS CAUSED BY HOUSEHOLD AND AMBIENT AIR POLLUTION, BY DISEASE 87
5.2.1.1.3 Growing tobacco consumption 87
TABLE 3 REGION-WISE DATA ON LIFESTYLE DISEASES 87
5.2.1.1.4 Increased adoption of sedentary lifestyles 88
5.2.1.2 Surging incidence rate of preterm births 88
TABLE 4 TOP 10 COUNTRIES WITH HIGHEST NUMBER OF PRETERM BIRTHS 88
TABLE 5 TOP 10 COUNTRIES WITH HIGHEST RATES OF PRETERM BIRTH PER 100 LIVE BIRTHS 89
5.2.1.3 Growing outbreaks of infectious diseases affecting respiratory systems 89
5.2.1.4 Rising population with sleep disorders 89
5.2.1.5 Improved patient outcomes using respiratory care devices 90
5.2.1.6 Surging R&D investments for technological advancement of medical devices 90
TABLE 6 PRODUCT LAUNCHES 91
5.2.2 RESTRAINTS 91
5.2.2.1 Unfavorable reimbursement scenario for respiratory care diagnostics 91
5.2.2.2 Availability of low-cost products from local manufacturers 91
5.2.2.3 High cost of CPAP machines 92
5.2.3 OPPORTUNITIES 92
5.2.3.1 Growing demand for home care therapeutic devices 92
5.2.3.2 Market growth opportunities in Asia Pacific and Latin America 93
5.2.3.3 Increasing preference for self-testing 93
5.2.3.4 Growing awareness about ill effects of untreated sleep apnea 94
TABLE 7 INITIATIVES TO PROMOTE AWARENESS ABOUT UNTREATED SLEEP APNEA 94
5.2.4 CHALLENGES 95
5.2.4.1 Low awareness and lack of diagnosis of respiratory diseases 95
5.2.4.2 Harmful effects of certain respiratory care devices on neonates 95
5.2.4.3 Lack of patient compliance with CPAP therapy 96
5.3 INDUSTRY TRENDS 96
5.3.1 RISING DEMAND FOR ENHANCED COMPACT AND PORTABLE DEVICES 96
5.3.2 KEY FOCUS OF MARKET PLAYERS ON GEOGRAPHICAL EXPANSION 96
5.3.3 GROWING DEMAND FOR MULTIMODAL VENTILATION 97
5.3.4 RISING ADOPTION OF NON-INVASIVE VENTILATION 97
FIGURE 29 IMPACT OF INNOVATIVE SOLUTIONS 97
FIGURE 30 INTRODUCTION OF INNOVATIVE SOLUTIONS FOR SLEEP APNEA TREATMENT 98
5.4 REGULATORY ANALYSIS 98
5.4.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 98
TABLE 8 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 98
TABLE 9 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 98
TABLE 10 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 99
5.4.2 NORTH AMERICA 99
5.4.2.1 US 99
TABLE 11 US: CLASSIFICATION OF MEDICAL EQUIPMENT 99
TABLE 12 US: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS 100
5.4.2.2 Canada 100
TABLE 13 CANADA: LEVEL OF RISK, TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS 100
5.4.3 EUROPE 100
TABLE 14 EUROPE: LEVEL OF RISK, TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS 101
5.4.4 ASIA PACIFIC 101
5.4.4.1 Japan 101
TABLE 15 JAPAN: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS 102
5.4.4.2 China 102
TABLE 16 CHINA: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS 102
5.4.4.3 India 103
5.5 ECOSYSTEM ANALYSIS 103
FIGURE 31 RESPIRATORY CARE DEVICES MARKET: ECOSYSTEM ANALYSIS 104
5.6 VALUE CHAIN ANALYSIS 104
FIGURE 32 RESPIRATORY CARE DEVICES MARKET: VALUE CHAIN ANALYSIS 105
5.7 IMPACT OF COVID-19 ON RESPIRATORY CARE DEVICES MARKET 105
5.8 TECHNOLOGY ANALYSIS 106
5.8.1 E-NOSE TECHNOLOGY 106
5.8.2 MEMS TECHNOLOGY 106
5.8.3 ELECTROCHEMICAL TECHNOLOGY 106
5.8.4 WIRELESS GAS SENSOR TECHNOLOGY 107
5.9 PATENT ANALYSIS 107
5.9.1 PATENT PUBLICATION TRENDS FOR RESPIRATORY CARE DEVICES 107
FIGURE 33 PATENT PUBLICATION TRENDS (2015–2023) 107
5.9.2 TOP APPLICANTS FOR RESPIRATORY CARE DEVICE PATENTS, BY GEOGRAPHY (2015–2023) 108
TABLE 17 TOP APPLICANTS FOR RESPIRATORY CARE DEVICE PATENTS, BY GEOGRAPHY 108
5.9.3 RESPIRATORY CARE DEVICES MARKET: TOP APPLICANTS 108
FIGURE 34 TOP APPLICANTS FOR RESPIRATORY CARE DEVICES PATENTS (2015–2023) 108
5.10 TRADE ANALYSIS 109
TABLE 18 TOP EXPORTERS OF MEDICAL VENTILATORS, CPAP, BIPAP, AND OXYGEN CONCENTRATORS, 2021 109
5.11 CASE STUDY ANALYSIS 110
TABLE 19 REPLACEMENT PATTERN OF VENTILATORS: DEVELOPED ECONOMIES VS. EMERGING ECONOMIES 110
TABLE 20 VOLUME DATA OF VENTILATORS, ICU VENTILATORS, PORTABLE VENTILATORS, PAP DEVICES, CPAP DEVICES, BIPAP DEVICES, AND SPIROMETERS 110
5.12 PORTER’S FIVE FORCES ANALYSIS 111
TABLE 21 PORTER’S FIVE FORCES ANALYSIS 111
5.12.1 THREAT OF NEW ENTRANTS 111
5.12.2 THREAT OF SUBSTITUTES 112
5.12.3 BARGAINING POWER OF SUPPLIERS 112
5.12.4 BARGAINING POWER OF BUYERS 112
5.12.5 INTENSITY OF COMPETITIVE RIVALRY 112
5.13 KEY CONFERENCES AND EVENTS, 2023–2024 113
5.13.1 RESPIRATORY CARE DEVICES MARKET: LIST OF KEY CONFERENCES AND EVENTS 113
5.14 KEY STAKEHOLDERS AND BUYING CRITERIA 113
5.14.1 KEY STAKEHOLDERS IN BUYING PROCESS 113
TABLE 22 STAKEHOLDERS IN BUYING PROCESS FOR RESPIRATORY CARE DEVICES 113
TABLE 23 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR RESPIRATORY CARE DEVICES 115
5.14.2 BUYING CRITERIA 115
FIGURE 35 KEY BUYING CRITERIA FOR RESPIRATORY DEVICES 115
TABLE 24 KEY BUYING CRITERIA FOR RESPIRATORY CARE DEVICES 115
5.15 PRICING ANALYSIS 116
TABLE 25 AVERAGE SELLING PRICE OF RESPIRATORY CARE DEVICES 116
5.16 UNMET NEEDS PERTAINING TO RESPIRATORY CARE DEVICES 116
TABLE 26 RESPIRATORY CARE DEVICES MARKET: UNMET NEEDS 116
5.16.1 END USER EXPECTATIONS 117
TABLE 27 RESPIRATORY CARE DEVICES MARKET: END USER EXPECTATIONS 117
5.17 APPLICATION OF ARTIFICIAL INTELLIGENCE IN RESPIRATORY CARE DEVICES 119
TABLE 28 RESPIRATORY CARE DEVICES MARKET: APPLICATION OF ARTIFICIAL INTELLIGENCE 119
5.17.1 FUTURE OF HEALTHCARE—BIG DATA AND ARTIFICIAL INTELLIGENCE 119
5.18 REIMBURSEMENT SCENARIO 120
TABLE 29 RESPIRATORY CARE DEVICES MARKET: REIMBURSEMENT SCENARIO 120
6 RESPIRATORY CARE DEVICES MARKET, BY PRODUCT 122
6.1 INTRODUCTION 123
TABLE 30 RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 123
TABLE 31 RESPIRATORY CARE DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 124
6.2 THERAPEUTIC RESPIRATORY CARE DEVICES 124
TABLE 32 THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 125
TABLE 33 THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 126
6.2.1 PAP DEVICES 126
TABLE 34 PAP DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 127
TABLE 35 PAP DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 127
TABLE 36 PAP DEVICES MARKET, BY REGION, 2021–2028 (THOUSAND UNITS) 128
6.2.1.1 CPAP devices 128
6.2.1.1.1 Growing popularity of nasal CPAP therapies to drive demand 128
TABLE 37 MAJOR PLAYERS OFFERING CPAP DEVICES IN MARKET 129
TABLE 38 CPAP DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 129
TABLE 39 CPAP DEVICES MARKET, BY REGION, 2021–2028 (THOUSAND UNITS) 130
6.2.1.2 APAP devices 130
6.2.1.2.1 Rising awareness among sleep specialists and patients regarding additional features of APAP devices to boost market 130
TABLE 40 MAJOR PLAYERS OFFERING APAP DEVICES IN MARKET 130
TABLE 41 APAP DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 131
TABLE 42 APAP DEVICES MARKET, BY REGION, 2021–2028 (THOUSAND UNITS) 131
6.2.1.3 BiPAP devices 132
6.2.1.3.1 Increasing number of hospitals to strengthen market 132
TABLE 43 MAJOR PLAYERS OFFERING BIPAP DEVICES IN MARKET 132
TABLE 44 BIPAP DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 133
TABLE 45 BIPAP DEVICES MARKET, BY REGION, 2021–2028 (THOUSAND UNITS) 133
6.2.2 VENTILATORS 134
TABLE 46 VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 134
TABLE 47 VENTILATORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 135
TABLE 48 VENTILATORS MARKET, BY REGION, 2021–2028 (THOUSAND UNITS) 135
6.2.2.1 ICU ventilators 136
TABLE 49 MAJOR PLAYERS OFFERING ICU VENTILATORS IN MARKET 136
TABLE 50 ICU VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 137
TABLE 51 ICU VENTILATORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 138
TABLE 52 ICU VENTILATORS MARKET, BY REGION, 2021–2028 (THOUSAND UNITS) 138
6.2.2.1.1 High-end ventilators 139
6.2.2.1.1.1 Improving healthcare infrastructure and rising healthcare expenditure to drive market 139
TABLE 53 HIGH-END VENTILATORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 139
TABLE 54 HIGH-END VENTILATORS MARKET, BY REGION, 2021–2028 (THOUSAND UNITS) 140
6.2.2.1.2 Mid-end ventilators 140
6.2.2.1.2.1 Better affordability and accessibility of mid-end ventilators than high-end models to support market growth 140
TABLE 55 MID-END VENTILATORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 141
TABLE 56 MID-END VENTILATORS MARKET, BY REGION, 2021–2028 (THOUSAND UNITS) 141
6.2.2.1.3 Basic ventilators 142
6.2.2.1.3.1 Expanding access to critical healthcare facilities in developing countries to spur demand 142
TABLE 57 BASIC VENTILATORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 142
TABLE 58 BASIC VENTILATORS MARKET, BY REGION, 2021–2028 (THOUSAND UNITS) 143
6.2.2.2 Portable/Transportable ventilators 143
6.2.2.2.1 Increasing demand for home care to boost segmental growth 143
TABLE 59 MAJOR PLAYERS OFFERING PORTABLE/TRANSPORTABLE VENTILATORS IN MARKET 144
TABLE 60 PORTABLE/TRANSPORTABLE VENTILATORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 145
TABLE 61 PORTABLE/TRANSPORTABLE VENTILATORS MARKET, BY REGION, 2021–2028 (THOUSAND UNITS) 146
6.2.3 NEBULIZERS 146
TABLE 62 MAJOR PLAYERS OFFERING NEBULIZERS IN MARKET 146
TABLE 63 NEBULIZERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 148
TABLE 64 NEBULIZERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 148
TABLE 65 NEBULIZERS MARKET, BY REGION, 2021–2028 (THOUSAND UNITS) 149
6.2.3.1 Jet nebulizers 149
6.2.3.1.1 Increasing prevalence of respiratory conditions to augment market size 149
TABLE 66 JET NEBULIZERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 150
TABLE 67 JET NEBULIZERS MARKET, BY REGION, 2021–2028 (THOUSAND UNITS) 150
6.2.3.2 Mesh nebulizers 151
6.2.3.2.1 Deployment of advanced aerosolization technology to drive market 151
TABLE 68 MESH NEBULIZERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 151
TABLE 69 MESH NEBULIZERS MARKET, BY REGION, 2021–2028 (THOUSAND UNITS) 152
6.2.3.3 Ultrasonic nebulizers 152
6.2.3.3.1 Adjustable settings for particle size and treatment duration to boost market 152
TABLE 70 ULTRASONIC NEBULIZERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 153
TABLE 71 ULTRASONIC NEBULIZERS MARKET, BY REGION, 2021–2028 (THOUSAND UNITS) 153
6.2.4 HUMIDIFIERS 154
TABLE 72 HUMIDIFIERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 154
TABLE 73 HUMIDIFIERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 155
TABLE 74 HUMIDIFIERS MARKET, BY REGION, 2021–2028 (THOUSAND UNITS) 155
6.2.4.1 Heated humidifiers 156
6.2.4.1.1 Ease of control and customizability to grow market 156
TABLE 75 MAJOR PLAYERS OFFERING HEATED HUMIDIFIERS IN MARKET 156
TABLE 76 HEATED HUMIDIFIERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 157
TABLE 77 HEATED HUMIDIFIERS MARKET, BY REGION, 2021–2028 (THOUSAND UNITS) 158
6.2.4.2 Passover humidifiers 158
6.2.4.2.1 Minimal maintenance and simple technology to spur demand 158
TABLE 78 MAJOR PLAYERS OFFERING PASSOVER HUMIDIFIERS IN MARKET 158
TABLE 79 PASSOVER HUMIDIFIERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 159
TABLE 80 PASSOVER HUMIDIFIERS MARKET, BY REGION, 2021–2028 (THOUSAND UNITS) 159
6.2.5 OXYGEN CONCENTRATORS 160
TABLE 81 MAJOR PLAYERS OFFERING OXYGEN CONCENTRATORS IN MARKET 160
TABLE 82 OXYGEN CONCENTRATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 160
TABLE 83 OXYGEN CONCENTRATORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 161
TABLE 84 OXYGEN CONCENTRATORS MARKET, BY REGION, 2021–2028 (THOUSAND UNITS) 161
6.2.5.1 Fixed oxygen concentrators 162
6.2.5.1.1 Better access to healthcare services to grow demand 162
TABLE 85 FIXED OXYGEN CONCENTRATORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 162
TABLE 86 FIXED OXYGEN CONCENTRATORS MARKET, BY REGION, 2021–2028 (THOUSAND UNITS) 163
6.2.5.2 Portable oxygen concentrators 163
6.2.5.2.1 Low weight and easy setup to drive segmental growth 163
TABLE 87 PORTABLE OXYGEN CONCENTRATORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 164
TABLE 88 PORTABLE OXYGEN CONCENTRATORS MARKET, BY REGION, 2021–2028 (THOUSAND UNITS) 164
6.2.6 INHALERS 165
TABLE 89 INHALERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 165
TABLE 90 INHALERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 166
TABLE 91 INHALERS MARKET, BY REGION, 2021–2028 (THOUSAND UNITS) 166
6.2.6.1 Metered-dose inhalers (MDIs) 167
6.2.6.1.1 Ongoing advancements in MDI technology to support market growth 167
TABLE 92 METERED-DOSE INHALERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 167
TABLE 93 METERED-DOSE INHALERS MARKET, BY REGION, 2021–2028 (THOUSAND UNITS) 168
6.2.6.2 Dry powder inhalers (DPIs) 168
6.2.6.2.1 Developments in particle engineering and powder formulations to boost segmental growth 168
TABLE 94 DRY POWDER INHALERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 169
TABLE 95 DRY POWDER INHALERS MARKET, BY REGION, 2021–2028 (THOUSAND UNITS) 169
6.2.7 REUSABLE RESUSCITATORS 170
6.2.7.1 Disposable and reusable nature to drive demand 170
TABLE 96 MAJOR PLAYERS OFFERING REUSABLE RESUSCITATORS IN MARKET 170
TABLE 97 REUSABLE RESUSCITATORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 171
TABLE 98 REUSABLE RESUSCITATORS MARKET, BY REGION, 2021–2028 (THOUSAND UNITS) 171
6.2.8 NITRIC OXIDE DELIVERY UNITS 172
6.2.8.1 Rising emphasis of companies on developing innovative and advanced nitric oxide delivery units to drive market 172
TABLE 99 MAJOR PLAYERS OFFERING NITRIC OXIDE DELIVERY UNITS IN MARKET 172
TABLE 100 NITRIC OXIDE DELIVERY UNITS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 173
TABLE 101 NITRIC OXIDE DELIVERY UNITS MARKET, BY REGION, 2021–2028 (THOUSAND UNITS) 173
6.2.9 OXYGEN HOODS 174
6.2.9.1 Growing prevalence of respiratory diseases in kids to drive market growth 174
TABLE 102 MAJOR PLAYERS OFFERING OXYGEN HOODS IN MARKET 174
TABLE 103 OXYGEN HOODS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 175
TABLE 104 OXYGEN HOODS MARKET, BY REGION, 2021–2028 (THOUSAND UNITS) 175
6.3 MONITORING DEVICES 176
TABLE 105 RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 176
TABLE 106 RESPIRATORY CARE MONITORING DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 177
6.3.1 PULSE OXIMETERS 177
TABLE 107 MAJOR PLAYERS OFFERING PULSE OXIMETERS IN MARKET 178
TABLE 108 PULSE OXIMETERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 178
TABLE 109 PULSE OXIMETERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 179
TABLE 110 PULSE OXIMETERS MARKET, BY REGION, 2021–2028 (THOUSAND UNITS) 179
6.3.1.1 Pulse oximeter sensors 180
6.3.1.1.1 Development of advanced sensors with embedded chips to boost segmental growth 180
TABLE 111 PULSE OXIMETER SENSORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 180
TABLE 112 PULSE OXIMETER SENSORS MARKET, BY REGION, 2021–2028 (THOUSAND UNITS) 181
6.3.1.2 Pulse oximeter equipment 181
6.3.1.2.1 Growing prevalence of chronic respiratory conditions to boost demand 181
TABLE 113 MAJOR PLAYERS OFFERING PULSE OXIMETER EQUIPMENT IN MARKET 181
TABLE 114 PULSE OXIMETER EQUIPMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 182
TABLE 115 PULSE OXIMETER EQUIPMENT MARKET, BY REGION, 2021–2028 (THOUSAND UNITS) 182
6.3.2 CAPNOGRAPHS 183
6.3.2.1 Ongoing R&D on capnographs to offer lucrative growth opportunities 183
TABLE 116 MAJOR PLAYERS OFFERING CAPNOGRAPHS IN MARKET 183
TABLE 117 CAPNOGRAPHS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 184
TABLE 118 CAPNOGRAPHS MARKET, BY REGION, 2021–2028 (THOUSAND UNITS) 184
6.3.3 GAS ANALYZERS 185
6.3.3.1 Increasing demand for point-of-care testing to drive demand 185
TABLE 119 MAJOR PLAYERS OFFERING GAS ANALYZERS IN MARKET 185
TABLE 120 GAS ANALYZERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 186
TABLE 121 GAS ANALYZERS MARKET, BY REGION, 2021–2028 (THOUSAND UNITS) 186
6.4 DIAGNOSTIC RESPIRATORY CARE DEVICES 187
TABLE 122 DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 187
TABLE 123 DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 188
6.4.1 SPIROMETERS 188
6.4.1.1 Rising technological advancements in spirometers to support market growth 188
TABLE 124 MAJOR PLAYERS OFFERING SPIROMETERS IN MARKET 189
TABLE 125 SPIROMETERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 190
TABLE 126 SPIROMETERS MARKET, BY REGION, 2021–2028 (THOUSAND UNITS) 190
6.4.2 POLYSOMNOGRAPHY DEVICES (PSG DEVICES) 191
6.4.2.1 Rising incidence of obstructive sleep apnea to drive demand 191
TABLE 127 MAJOR PLAYERS OFFERING POLYSOMNOGRAPHY DEVICES IN MARKET 191
TABLE 128 POLYSOMNOGRAPHY DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 192
TABLE 129 POLYSOMNOGRAPHY DEVICES MARKET, BY REGION, 2021–2028 (THOUSAND UNITS) 192
6.4.3 PEAK FLOW METERS 193
6.4.3.1 Low-cost and uncomplicated nature to drive segmental growth 193
TABLE 130 MAJOR PLAYERS OFFERING PEAK FLOW METERS IN MARKET 193
TABLE 131 PEAK FLOW METERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 194
TABLE 132 PEAK FLOW METERS MARKET, BY REGION, 2021–2028 (THOUSAND UNITS) 194
6.4.4 OTHER DIAGNOSTIC DEVICES 195
TABLE 133 OTHER DIAGNOSTIC DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 195
6.5 CONSUMABLES & ACCESSORIES 196
TABLE 134 RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2021–2028 (USD MILLION) 196
TABLE 135 RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 197
6.5.1 MASKS 197
TABLE 136 MASKS MARKET, BY TYPE, 2021–2028 (USD MILLION) 198
TABLE 137 MASKS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 198
6.5.1.1 Reusable masks 199
6.5.1.1.1 Growing concerns related to air pollution to grow demand 199
TABLE 138 REUSABLE MASKS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 199
6.5.1.2 Disposable masks 200
6.5.1.2.1 Stringent government mandates on wearing masks to spur demand 200
TABLE 139 DISPOSABLE MASKS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 200
6.5.2 DISPOSABLE RESUSCITATORS 201
6.5.2.1 Growing focus on reducing cross-contamination cases in patients to foster segmental growth 201
TABLE 140 DISPOSABLE RESUSCITATORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 201
6.5.3 TRACHEOSTOMY TUBES 202
6.5.3.1 Introduction of new and advanced products with ergonomic designs to drive market growth 202
TABLE 141 TRACHEOSTOMY TUBES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 202
6.5.4 BREATHING CIRCUITS 203
6.5.4.1 Healthcare professionals’ efforts to improve infection control practices to grow demand 203
TABLE 142 BREATHING CIRCUITS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 203
6.5.5 NASAL CANNULAE 204
6.5.5.1 Increasing focus on minimally invasive surgery techniques to fuel demand 204
TABLE 143 NASAL CANNULAE MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 204
6.5.6 OTHER CONSUMABLES & ACCESSORIES 205
TABLE 144 OTHER CONSUMABLES & ACCESSORIES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 205
7 RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION 206
7.1 INTRODUCTION 207
TABLE 145 RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2021–2028 (USD MILLION) 207
7.2 CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) 207
7.2.1 RISING INDOOR AND OUTDOOR AIR POLLUTION LEVELS TO DRIVE MARKET 207
TABLE 146 RESPIRATORY CARE DEVICES MARKET FOR COPD, BY COUNTRY, 2021–2028 (USD MILLION) 208
7.3 SLEEP APNEA 209
7.3.1 GROWING INCIDENCE OF OBESITY AND CARDIOVASCULAR DISEASES TO FAVOR MARKET GROWTH 209
TABLE 147 COUNTRY-WISE DATA ON SLEEP APNEA PATIENTS 209
TABLE 148 RESPIRATORY CARE DEVICES MARKET FOR SLEEP APNEA, BY COUNTRY, 2021–2028 (USD MILLION) 210
7.4 ASTHMA 211
7.4.1 INCREASING INCIDENCE OF COPD TO DRIVE MARKET 211
TABLE 149 RESPIRATORY CARE DEVICES MARKET FOR ASTHMA, BY COUNTRY, 2021–2028 (USD MILLION) 211
7.5 INFECTIOUS DISEASES 212
7.5.1 GROWING NUMBER OF TB PATIENTS TO BOOST MARKET GROWTH 212
TABLE 150 INCIDENCE OF TB (RATE PER 100,000 POPULATION) 212
TABLE 151 RESPIRATORY CARE DEVICES MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2021–2028 (USD MILLION) 213
7.6 OTHER DISEASE INDICATIONS 213
TABLE 152 RESPIRATORY CARE DEVICES MARKET FOR OTHER DISEASE INDICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 214
8 RESPIRATORY CARE DEVICES MARKET, BY END USER 215
8.1 INTRODUCTION 216
TABLE 153 RESPIRATORY CARE DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 216
8.2 HOSPITALS 216
8.2.1 GROWING NUMBER OF HOSPITALS IN EMERGING ECONOMIES TO DRIVE MARKET 216
TABLE 154 RESPIRATORY CARE DEVICES MARKET FOR HOSPITALS, BY COUNTRY, 2021–2028 (USD MILLION) 217
8.3 HOME CARE SETTINGS 218
8.3.1 INCREASING ACCEPTANCE OF HOME CARE DEVICES BY PATIENTS TO BOOST GROWTH 218
TABLE 155 RESPIRATORY CARE DEVICES MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2021–2028 (USD MILLION) 219
8.4 AMBULATORY CARE CENTERS (ACCS) 219
8.4.1 IMPROVED PATIENT EXPERIENCE IN AMBULATORY CARE CENTERS TO DRIVE MARKET 219
TABLE 156 RESPIRATORY CARE DEVICES MARKET FOR AMBULATORY CARE CENTERS, BY COUNTRY, 2021–2028 (USD MILLION) 220
8.5 OTHER END USERS 221
TABLE 157 RESPIRATORY CARE DEVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION) 221
9 RESPIRATORY CARE DEVICES MARKET, BY REGION 222
9.1 INTRODUCTION 223
FIGURE 36 RESPIRATORY CARE DEVICES MARKET: REGIONAL GROWTH OPPORTUNITIES 223
TABLE 158 RESPIRATORY CARE DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION) 224
9.2 NORTH AMERICA 225
FIGURE 37 NORTH AMERICA: RESPIRATORY CARE DEVICES MARKET SNAPSHOT 225
TABLE 159 NORTH AMERICA: RESPIRATORY CARE DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 226
TABLE 160 NORTH AMERICA: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 226
TABLE 161 NORTH AMERICA: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 227
TABLE 162 NORTH AMERICA: PAP DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 227
TABLE 163 NORTH AMERICA: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 227
TABLE 164 NORTH AMERICA: VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 228
TABLE 165 NORTH AMERICA: ICU VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 228
TABLE 166 NORTH AMERICA: INHALERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 228
TABLE 167 NORTH AMERICA: HUMIDIFIERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 229
TABLE 168 NORTH AMERICA: NEBULIZERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 229
TABLE 169 NORTH AMERICA: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 229
TABLE 170 NORTH AMERICA: PULSE OXIMETERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 230
TABLE 171 NORTH AMERICA: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 230
TABLE 172 NORTH AMERICA: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2021–2028 (USD MILLION) 230
TABLE 173 NORTH AMERICA: MASKS MARKET, BY TYPE, 2021–2028 (USD MILLION) 231
TABLE 174 NORTH AMERICA: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2021–2028 (USD MILLION) 231
TABLE 175 NORTH AMERICA: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 231
9.2.1 NORTH AMERICA: RECESSION IMPACT 232
9.2.2 US 232
9.2.2.1 Rapid growth in geriatric population to boost market 232
TABLE 176 US: KEY MACROINDICATORS 233
TABLE 177 US: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 233
TABLE 178 US: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 234
TABLE 179 US: PAP DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 234
TABLE 180 US: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 234
TABLE 181 US: VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 235
TABLE 182 US: ICU VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 235
TABLE 183 US: INHALERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 235
TABLE 184 US: HUMIDIFIERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 236
TABLE 185 US: NEBULIZERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 236
TABLE 186 US: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 236
TABLE 187 US: PULSE OXIMETERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 237
TABLE 188 US: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 237
TABLE 189 US: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2021–2028 (USD MILLION) 237
TABLE 190 US: MASKS MARKET, BY TYPE, 2021–2028 (USD MILLION) 238
TABLE 191 US: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2021–2028 (USD MILLION) 238
TABLE 192 US: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 238
9.2.3 CANADA 239
9.2.3.1 Large pool of undiagnosed patients to drive market 239
TABLE 193 CANADA: COPD AND ASTHMA STATISTICS (2019 VS. 2020) 239
TABLE 194 CANADA: KEY MACROINDICATORS 239
TABLE 195 CANADA: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 240
TABLE 196 CANADA: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 240
TABLE 197 CANADA: PAP DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 241
TABLE 198 CANADA: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 241
TABLE 199 CANADA: VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 241
TABLE 200 CANADA: ICU VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 242
TABLE 201 CANADA: INHALERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 242
TABLE 202 CANADA: HUMIDIFIERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 242
TABLE 203 CANADA: NEBULIZERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 243
TABLE 204 CANADA: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 243
TABLE 205 CANADA: PULSE OXIMETERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 243
TABLE 206 CANADA: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 244
TABLE 207 CANADA: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2021–2028 (USD MILLION) 244
TABLE 208 CANADA: MASKS MARKET, BY TYPE, 2021–2028 (USD MILLION) 244
TABLE 209 CANADA: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2021–2028 (USD MILLION) 245
TABLE 210 CANADA: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 245
9.3 EUROPE 245
TABLE 211 EUROPE: RESPIRATORY CARE DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 246
TABLE 212 EUROPE: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 246
TABLE 213 EUROPE: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 247
TABLE 214 EUROPE: PAP DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 247
TABLE 215 EUROPE: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 247
TABLE 216 EUROPE: VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 248
TABLE 217 EUROPE: ICU VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 248
TABLE 218 EUROPE: INHALERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 248
TABLE 219 EUROPE: HUMIDIFIERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 249
TABLE 220 EUROPE: NEBULIZER MARKET, BY TYPE, 2021–2028 (USD MILLION) 249
TABLE 221 EUROPE: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 249
TABLE 222 EUROPE: PULSE OXIMETERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 250
TABLE 223 EUROPE: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 250
TABLE 224 EUROPE: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2021–2028 (USD MILLION) 250
TABLE 225 EUROPE: MASKS MARKET, BY TYPE, 2021–2028 (USD MILLION) 251
TABLE 226 EUROPE: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2021–2028 (USD MILLION) 251
TABLE 227 EUROPE: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 251
9.3.1 EUROPE: RECESSION IMPACT 252
9.3.2 GERMANY 252
9.3.2.1 Increasing public healthcare expenditure to foster market growth 252
TABLE 228 GERMANY: KEY MACROINDICATORS 252
TABLE 229 GERMANY: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 253
TABLE 230 GERMANY: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 253
TABLE 231 GERMANY: PAP DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 254
TABLE 232 GERMANY: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 254
TABLE 233 GERMANY: VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 254
TABLE 234 GERMANY: ICU VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 255
TABLE 235 GERMANY: INHALERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 255
TABLE 236 GERMANY: HUMIDIFIERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 255
TABLE 237 GERMANY: NEBULIZERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 256
TABLE 238 GERMANY: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 256
TABLE 239 GERMANY: PULSE OXIMETERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 256
TABLE 240 GERMANY: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 257
TABLE 241 GERMANY: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2021–2028 (USD MILLION) 257
TABLE 242 GERMANY: MASKS MARKET, BY TYPE, 2021–2028 (USD MILLION) 257

TABLE 243 GERMANY: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2021–2028 (USD MILLION) 258
TABLE 244 GERMANY: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 258
9.3.3 FRANCE 258
9.3.3.1 High prevalence of COPD to surge demand 258
TABLE 245 FRANCE: KEY MACROINDICATORS 259
TABLE 246 FRANCE: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 259
TABLE 247 FRANCE: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 260
TABLE 248 FRANCE: PAP DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 260
TABLE 249 FRANCE: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 260
TABLE 250 FRANCE: VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 261
TABLE 251 FRANCE: ICU VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 261
TABLE 252 FRANCE: INHALERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 261
TABLE 253 FRANCE: HUMIDIFIERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 261
TABLE 254 FRANCE: NEBULIZERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 262
TABLE 255 FRANCE: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 262
TABLE 256 FRANCE: PULSE OXIMETERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 262
TABLE 257 FRANCE: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 263
TABLE 258 FRANCE: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2021–2028 (USD MILLION) 263
TABLE 259 FRANCE: MASKS MARKET, BY TYPE, 2021–2028 (USD MILLION) 263
TABLE 260 FRANCE: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2021–2028 (USD MILLION) 264
TABLE 261 FRANCE: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 264
9.3.4 UK 264
9.3.4.1 Growing demand for minimally invasive surgeries to drive market 264
TABLE 262 UK: KEY MACROINDICATORS 265
TABLE 263 UK: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 265
TABLE 264 UK: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 266
TABLE 265 UK: PAP DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 266
TABLE 266 UK: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 266
TABLE 267 UK: VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 267
TABLE 268 UK: ICU VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 267
TABLE 269 UK: INHALERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 267
TABLE 270 UK: HUMIDIFIERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 268
TABLE 271 UK: NEBULIZERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 268
TABLE 272 UK: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 268
TABLE 273 UK: PULSE OXIMETERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 269
TABLE 274 UK: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 269
TABLE 275 UK: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2021–2028 (USD MILLION) 269
TABLE 276 UK: MASKS MARKET, BY TYPE, 2021–2028 (USD MILLION) 270
TABLE 277 UK: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2021–2028 (USD MILLION) 270
TABLE 278 UK: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 270
9.3.5 ITALY 271
9.3.5.1 Growing involvement of private sector in healthcare market to drive market 271
TABLE 279 ITALY: KEY MACROINDICATORS 271
TABLE 280 ITALY: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 272
TABLE 281 ITALY: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 272
TABLE 282 ITALY: PAP DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 273
TABLE 283 ITALY: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 273
TABLE 284 ITALY: VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 273
TABLE 285 ITALY: ICU VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 273
TABLE 286 ITALY: INHALERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 274
TABLE 287 ITALY: HUMIDIFIERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 274
TABLE 288 ITALY: NEBULIZERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 274
TABLE 289 ITALY: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 275
TABLE 290 ITALY: PULSE OXIMETERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 275
TABLE 291 ITALY: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 275
TABLE 292 ITALY: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2021–2028 (USD MILLION) 276
TABLE 293 ITALY: MASKS MARKET, BY TYPE, 2021–2028 (USD MILLION) 276
TABLE 294 ITALY: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2021–2028 (USD MILLION) 276
TABLE 295 ITALY: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 277
9.3.6 SPAIN 277
9.3.6.1 Need to improve healthcare infrastructure due to aging demographic to drive demand 277
TABLE 296 SPAIN: KEY MACROINDICATORS 278
TABLE 297 SPAIN: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 278
TABLE 298 SPAIN: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 279
TABLE 299 SPAIN: PAP DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 279
TABLE 300 SPAIN: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 279
TABLE 301 SPAIN: VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 280
TABLE 302 SPAIN: ICU VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 280
TABLE 303 SPAIN: INHALERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 280
TABLE 304 SPAIN: HUMIDIFIERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 280
TABLE 305 SPAIN: NEBULIZERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 281
TABLE 306 SPAIN: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 281
TABLE 307 SPAIN: PULSE OXIMETERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 281
TABLE 308 SPAIN: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 282
TABLE 309 SPAIN: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2021–2028 (USD MILLION) 282
TABLE 310 SPAIN: MASKS MARKET, BY TYPE, 2021–2028 (USD MILLION) 282
TABLE 311 SPAIN: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2021–2028 (USD MILLION) 283
TABLE 312 SPAIN: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 283
9.3.7 REST OF EUROPE 283
TABLE 313 REST OF EUROPE: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 284
TABLE 314 REST OF EUROPE: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 284
TABLE 315 REST OF EUROPE: PAP DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 285
TABLE 316 REST OF EUROPE: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 285
TABLE 317 REST OF EUROPE: VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 285
TABLE 318 REST OF EUROPE: ICU VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 286
TABLE 319 REST OF EUROPE: INHALERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 286
TABLE 320 REST OF EUROPE: HUMIDIFIERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 286
TABLE 321 REST OF EUROPE: NEBULIZERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 286
TABLE 322 REST OF EUROPE: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 287
TABLE 323 REST OF EUROPE: PULSE OXIMETERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 287
TABLE 324 REST OF EUROPE: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 287
TABLE 325 REST OF EUROPE: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2021–2028 (USD MILLION) 288
TABLE 326 REST OF EUROPE: MASKS MARKET, BY TYPE, 2021–2028 (USD MILLION) 288
TABLE 327 REST OF EUROPE: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2021–2028 (USD MILLION) 288
TABLE 328 REST OF EUROPE: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 289

9.4 ASIA PACIFIC 289
FIGURE 38 ASIA PACIFIC: RESPIRATORY CARE DEVICES MARKET SNAPSHOT 290
TABLE 329 ASIA PACIFIC: RESPIRATORY CARE DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 291
TABLE 330 ASIA PACIFIC: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 291
TABLE 331 ASIA PACIFIC: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 292
TABLE 332 ASIA PACIFIC: PAP DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 292
TABLE 333 ASIA PACIFIC: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 292
TABLE 334 ASIA PACIFIC: VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 293
TABLE 335 ASIA PACIFIC: ICU VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 293
TABLE 336 ASIA PACIFIC: INHALERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 293
TABLE 337 ASIA PACIFIC: HUMIDIFIERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 293
TABLE 338 ASIA PACIFIC: NEBULIZERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 294
TABLE 339 ASIA PACIFIC: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 294
TABLE 340 ASIA PACIFIC: PULSE OXIMETERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 294
TABLE 341 ASIA PACIFIC: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 295
TABLE 342 ASIA PACIFIC: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2021–2028 (USD MILLION) 295
TABLE 343 ASIA PACIFIC: MASKS MARKET, BY TYPE, 2021–2028 (USD MILLION) 295
TABLE 344 ASIA PACIFIC: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2021–2028 (USD MILLION) 296
TABLE 345 ASIA PACIFIC: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 296
9.4.1 ASIA PACIFIC: RECESSION IMPACT 296
9.4.2 JAPAN 297
9.4.2.1 Availability of universal healthcare reimbursement policy to drive market 297
TABLE 346 JAPAN: KEY MACROINDICATORS 297
TABLE 347 JAPAN: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 298
TABLE 348 JAPAN: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 298
TABLE 349 JAPAN: PAP DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 299
TABLE 350 JAPAN: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 299
TABLE 351 JAPAN: VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 299
TABLE 352 JAPAN: ICU VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 300
TABLE 353 JAPAN: INHALERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 300
TABLE 354 JAPAN: HUMIDIFIERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 300
TABLE 355 JAPAN: NEBULIZERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 301
TABLE 356 JAPAN: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 301
TABLE 357 JAPAN: PULSE OXIMETERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 301
TABLE 358 JAPAN: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 302
TABLE 359 JAPAN: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2021–2028 (USD MILLION) 302
TABLE 360 JAPAN: MASKS MARKET, BY TYPE, 2021–2028 (USD MILLION) 302
TABLE 361 JAPAN: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2021–2028 (USD MILLION) 303
TABLE 362 JAPAN: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 303
9.4.3 CHINA 303
9.4.3.1 Initiatives to modernize healthcare system and reimbursement facilities to support market growth 303
TABLE 363 CHINA: KEY MACROINDICATORS 304
TABLE 364 CHINA: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 304
TABLE 365 CHINA: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 305
TABLE 366 CHINA: PAP DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 305
TABLE 367 CHINA: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 305
TABLE 368 CHINA: VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 306
TABLE 369 CHINA: ICU VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 306
TABLE 370 CHINA: INHALERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 306
TABLE 371 CHINA: HUMIDIFIERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 306
TABLE 372 CHINA: NEBULIZERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 307
TABLE 373 CHINA: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 307
TABLE 374 CHINA: PULSE OXIMETERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 307
TABLE 375 CHINA: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 308
TABLE 376 CHINA: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2021–2028 (USD MILLION) 308
TABLE 377 CHINA: MASKS MARKET, BY TYPE, 2021–2028 (USD MILLION) 308
TABLE 378 CHINA: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2021–2028 (USD MILLION) 309
TABLE 379 CHINA: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 309
9.4.4 INDIA 309
9.4.4.1 Increasing focus of global players on domestic market to drive market 309
TABLE 380 INDIA: KEY MACROINDICATORS 310
TABLE 381 INDIA: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 310
TABLE 382 INDIA: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 311
TABLE 383 INDIA: PAP DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 311
TABLE 384 INDIA: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 311
TABLE 385 INDIA: VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 312
TABLE 386 INDIA: ICU VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 312
TABLE 387 INDIA: INHALERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 312
TABLE 388 INDIA: HUMIDIFIERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 312
TABLE 389 INDIA: NEBULIZERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 313
TABLE 390 INDIA: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 313
TABLE 391 INDIA: PULSE OXIMETERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 313
TABLE 392 INDIA: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 314
TABLE 393 INDIA: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2021–2028 (USD MILLION) 314
TABLE 394 INDIA: MASKS MARKET, BY TYPE, 2021–2028 (USD MILLION) 314
TABLE 395 INDIA: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2021–2028 (USD MILLION) 315
TABLE 396 INDIA: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 315
9.4.5 AUSTRALIA 315
9.4.5.1 High prevalence of chronic lung diseases to drive demand 315
TABLE 397 AUSTRALIA: KEY MACROINDICATORS 316
TABLE 398 AUSTRALIA: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 316
TABLE 399 AUSTRALIA: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 317
TABLE 400 AUSTRALIA: PAP DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 317
TABLE 401 AUSTRALIA: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 317
TABLE 402 AUSTRALIA: VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 318
TABLE 403 AUSTRALIA: ICU VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 318
TABLE 404 AUSTRALIA: INHALERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 318
TABLE 405 AUSTRALIA: HUMIDIFIERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 318
TABLE 406 AUSTRALIA: NEBULIZERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 319
TABLE 407 AUSTRALIA: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 319
TABLE 408 AUSTRALIA: PULSE OXIMETERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 319
TABLE 409 AUSTRALIA: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 320
TABLE 410 AUSTRALIA: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2021–2028 (USD MILLION) 320
TABLE 411 AUSTRALIA: MASKS MARKET, BY TYPE, 2021–2028 (USD MILLION) 320
TABLE 412 AUSTRALIA: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2021–2028 (USD MILLION) 321
TABLE 413 AUSTRALIA: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 321
9.4.6 SOUTH KOREA 321
9.4.6.1 Expanding geriatric population to fuel market 321
TABLE 414 SOUTH KOREA: KEY MACROINDICATORS 322
TABLE 415 SOUTH KOREA: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 322
TABLE 416 SOUTH KOREA: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 322
TABLE 417 SOUTH KOREA: PAP DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 323
TABLE 418 SOUTH KOREA: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 323
TABLE 419 SOUTH KOREA: VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 323
TABLE 420 SOUTH KOREA: ICU VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 323
TABLE 421 SOUTH KOREA: INHALERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 324
TABLE 422 SOUTH KOREA: HUMIDIFIERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 324
TABLE 423 SOUTH KOREA: NEBULIZERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 324
TABLE 424 SOUTH KOREA: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 325
TABLE 425 SOUTH KOREA: PULSE OXIMETERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 325
TABLE 426 SOUTH KOREA: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 325
TABLE 427 SOUTH KOREA: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2021–2028 (USD MILLION) 326
TABLE 428 SOUTH KOREA: MASKS MARKET, BY TYPE, 2021–2028 (USD MILLION) 326
TABLE 429 SOUTH KOREA: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2021–2028 (USD MILLION) 327
TABLE 430 SOUTH KOREA: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 327
9.4.7 REST OF ASIA PACIFIC 327
TABLE 431 REST OF ASIA PACIFIC: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 328
TABLE 432 REST OF ASIA PACIFIC: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 328
TABLE 433 REST OF ASIA PACIFIC: PAP DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 329
TABLE 434 REST OF ASIA PACIFIC: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 329
TABLE 435 REST OF ASIA PACIFIC: VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 329
TABLE 436 REST OF ASIA PACIFIC: ICU VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 329
TABLE 437 REST OF ASIA PACIFIC: INHALERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 330
TABLE 438 REST OF ASIA PACIFIC: HUMIDIFIERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 330
TABLE 439 REST OF ASIA PACIFIC: NEBULIZERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 330
TABLE 440 REST OF ASIA PACIFIC: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 331
TABLE 441 REST OF ASIA PACIFIC: PULSE OXIMETERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 331
TABLE 442 REST OF ASIA PACIFIC: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 331
TABLE 443 REST OF ASIA PACIFIC: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2021–2028 (USD MILLION) 332
TABLE 444 REST OF ASIA PACIFIC: MASKS MARKET, BY TYPE, 2021–2028 (USD MILLION) 332
TABLE 445 REST OF ASIA PACIFIC: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2021–2028 (USD MILLION) 332
TABLE 446 REST OF ASIA PACIFIC: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 333
9.5 LATIN AMERICA 333
TABLE 447 LATIN AMERICA: RESPIRATORY CARE DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 333
TABLE 448 LATIN AMERICA: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 334
TABLE 449 LATIN AMERICA: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 334
TABLE 450 LATIN AMERICA: PAP DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 335
TABLE 451 LATIN AMERICA: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 335
TABLE 452 LATIN AMERICA: VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 335
TABLE 453 LATIN AMERICA: ICU VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 336
TABLE 454 LATIN AMERICA: INHALERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 336
TABLE 455 LATIN AMERICA: HUMIDIFIERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 336
TABLE 456 LATIN AMERICA: NEBULIZERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 336
TABLE 457 LATIN AMERICA: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 337
TABLE 458 LATIN AMERICA: PULSE OXIMETERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 337
TABLE 459 LATIN AMERICA: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 337
TABLE 460 LATIN AMERICA: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2021–2028 (USD MILLION) 338
TABLE 461 LATIN AMERICA: MASKS MARKET, BY TYPE, 2021–2028 (USD MILLION) 338
TABLE 462 LATIN AMERICA: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2021–2028 (USD MILLION) 338
TABLE 463 LATIN AMERICA: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 339
9.5.1 LATIN AMERICA: RECESSION IMPACT 339
9.5.2 BRAZIL 339
9.5.2.1 Government initiatives to improve healthcare sector to drive market 339
TABLE 464 BRAZIL: KEY MACROINDICATORS 340
TABLE 465 BRAZIL: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 340
TABLE 466 BRAZIL: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 341
TABLE 467 BRAZIL: PAP DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 341
TABLE 468 BRAZIL: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 341
TABLE 469 BRAZIL: VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 342
TABLE 470 BRAZIL: ICU VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 342
TABLE 471 BRAZIL: INHALERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 342
TABLE 472 BRAZIL: HUMIDIFIERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 342
TABLE 473 BRAZIL: NEBULIZERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 343
TABLE 474 BRAZIL: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 343
TABLE 475 BRAZIL: PULSE OXIMETERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 343
TABLE 476 BRAZIL: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 344
TABLE 477 BRAZIL: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2021–2028 (USD MILLION) 344
TABLE 478 BRAZIL: MASKS MARKET, BY TYPE, 2021–2028 (USD MILLION) 344
TABLE 479 BRAZIL: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2021–2028 (USD MILLION) 345
TABLE 480 BRAZIL: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 345
9.5.3 MEXICO 345
9.5.3.1 Rising obesity rate to increase incidence of respiratory diseases 345
TABLE 481 MEXICO: KEY MACROINDICATORS 346
TABLE 482 MEXICO: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 346
TABLE 483 MEXICO: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 347
TABLE 484 MEXICO: PAP DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 347
TABLE 485 MEXICO: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 347
TABLE 486 MEXICO: VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 348
TABLE 487 MEXICO: ICU VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 348
TABLE 488 MEXICO: INHALERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 348
TABLE 489 MEXICO: HUMIDIFIERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 348
TABLE 490 MEXICO: NEBULIZERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 349
TABLE 491 MEXICO: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 349
TABLE 492 MEXICO: PULSE OXIMETERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 349
TABLE 493 MEXICO: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 350
TABLE 494 MEXICO: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2021–2028 (USD MILLION) 350
TABLE 495 MEXICO: MASKS MARKET, BY TYPE, 2021–2028 (USD MILLION) 350
TABLE 496 MEXICO: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2021–2028 (USD MILLION) 351
TABLE 497 MEXICO: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 351
9.5.4 REST OF LATIN AMERICA 351
TABLE 498 REST OF LATIN AMERICA: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 352
TABLE 499 REST OF LATIN AMERICA: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 352
TABLE 500 REST OF LATIN AMERICA: PAP DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 353
TABLE 501 REST OF LATIN AMERICA: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 353
TABLE 502 REST OF LATIN AMERICA: VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 353
TABLE 503 REST OF LATIN AMERICA: ICU VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 354
TABLE 504 REST OF LATIN AMERICA: INHALERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 354
TABLE 505 REST OF LATIN AMERICA: HUMIDIFIERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 354
TABLE 506 REST OF LATIN AMERICA: NEBULIZERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 355
TABLE 507 REST OF LATIN AMERICA: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 355
TABLE 508 REST OF LATIN AMERICA: PULSE OXIMETERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 355
TABLE 509 REST OF LATIN AMERICA: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 356
TABLE 510 REST OF LATIN AMERICA: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2021–2028 (USD MILLION) 356
TABLE 511 REST OF LATIN AMERICA: MASKS MARKET, BY TYPE, 2021–2028 (USD MILLION) 356
TABLE 512 REST OF LATIN AMERICA: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2021–2028 (USD MILLION) 357
TABLE 513 REST OF LATIN AMERICA: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 357
9.6 MIDDLE EAST & AFRICA 357
9.6.1 PRESENCE OF UNSATURATED MARKETS TO OFFER LUCRATIVE GROWTH OPPORTUNITIES TO PLAYERS 357
TABLE 514 MIDDLE EAST & AFRICA: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 358
TABLE 515 MIDDLE EAST & AFRICA: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 358
TABLE 516 MIDDLE EAST & AFRICA: PAP DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 359
TABLE 517 MIDDLE EAST & AFRICA: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 359
TABLE 518 MIDDLE EAST & AFRICA: VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 359
TABLE 519 MIDDLE EAST & AFRICA: ICU VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 359
TABLE 520 MIDDLE EAST & AFRICA: INHALERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 360
TABLE 521 MIDDLE EAST & AFRICA: HUMIDIFIERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 360
TABLE 522 MIDDLE EAST & AFRICA: NEBULIZERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 360
TABLE 523 MIDDLE EAST & AFRICA: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 361
TABLE 524 MIDDLE EAST & AFRICA: PULSE OXIMETERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 361
TABLE 525 MIDDLE EAST & AFRICA: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 361
TABLE 526 MIDDLE EAST & AFRICA: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2021–2028 (USD MILLION) 362
TABLE 527 MIDDLE EAST & AFRICA: MASKS MARKET, BY TYPE, 2021–2028 (USD MILLION) 362
TABLE 528 MIDDLE EAST & AFRICA: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2021–2028 (USD MILLION) 362
TABLE 529 MIDDLE EAST & AFRICA: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 363
9.6.2 MIDDLE EAST & AFRICA: RECESSION IMPACT 363
10 COMPETITIVE LANDSCAPE 364
10.1 INTRODUCTION 364
10.2 RIGHT TO WIN/KEY STRATEGIES 364
10.3 STRATEGIES ADOPTED BY KEY PLAYERS 365
10.4 REVENUE ANALYSIS FOR TOP FIVE MARKET PLAYERS 366
FIGURE 39 REVENUE ANALYSIS OF TOP FIVE PLAYERS IN RESPIRATORY CARE DEVICES MARKET 366
10.5 MARKET SHARE ANALYSIS 366
FIGURE 40 RESPIRATORY CARE DEVICES MARKET SHARE, BY KEY PLAYER (2022) 367
FIGURE 41 SHARE OF LEADING COMPANIES IN GLOBAL THERAPEUTIC RESPIRATORY CARE DEVICES MARKET (2022) 367
FIGURE 42 SHARE OF LEADING COMPANIES IN GLOBAL MONITORING DEVICES MARKET (2022) 368
FIGURE 43 SHARE OF LEADING COMPANIES IN GLOBAL DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET (2022) 368
10.6 COMPANY EVALUATION MATRIX 369
10.6.1 STARS 369
10.6.2 EMERGING LEADERS 369
10.6.3 PERVASIVE PLAYERS 369
10.6.4 PARTICIPANTS 370
FIGURE 44 RESPIRATORY CARE DEVICES MARKET: COMPETITIVE LEADERSHIP MATRIX, 2022 370
10.7 COMPANY EVALUATION MATRIX FOR SMES/START-UPS (2022) 371
10.7.1 PROGRESSIVE COMPANIES 371
10.7.2 DYNAMIC COMPANIES 371
10.7.3 STARTING BLOCKS 371
10.7.4 RESPONSIVE COMPANIES 371
FIGURE 45 RESPIRATORY CARE DEVICES MARKET: COMPANY EVALUATION MATRIX FOR SMES/START-UPS, 2022 372
10.8 COMPETITIVE BENCHMARKING 373
TABLE 530 RESPIRATORY CARE DEVICES MARKET: KEY STARTUPS/SMES 373
10.8.1 COMPANY FOOTPRINT 374
TABLE 531 FOOTPRINT OF COMPANIES, BY OFFERING (25 COMPANIES) 374
TABLE 532 FOOTPRINT OF COMPANIES, BY DISEASE INDICATION (25 COMPANIES) 375
TABLE 533 FOOTPRINT OF COMPANIES, BY END USER (25 COMPANIES) 377
FIGURE 46 OVERALL FOOTPRINT OF COMPANIES (25 COMPANIES) 378
10.8.2 COMPETITIVE SCENARIOS AND TRENDS 378
10.8.3 PRODUCT LAUNCHES 379
TABLE 534 RESPIRATORY CARE DEVICES MARKET: PRODUCT LAUNCHES (2019–2023) 379
10.8.4 DEALS 379
TABLE 535 RESPIRATORY CARE DEVICES MARKET: DEALS (2019–2023) 379
11 COMPANY PROFILES 381
11.1 KEY PLAYERS 381
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
11.1.1 KONINKLIJKE PHILIPS N.V. 381
TABLE 536 KONINKLIJKE PHILIPS N.V.: BUSINESS OVERVIEW 381
FIGURE 47 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2022) 382
11.1.2 MEDTRONIC 386
TABLE 537 MEDTRONIC: BUSINESS OVERVIEW 386
FIGURE 48 MEDTRONIC: COMPANY SNAPSHOT (2022) 387
11.1.3 RESMED 391
TABLE 538 RESMED: BUSINESS OVERVIEW 391
FIGURE 49 RESMED: COMPANY SNAPSHOT (2022) 392
11.1.4 MASIMO 398
TABLE 539 MASIMO: BUSINESS OVERVIEW 398
FIGURE 50 MASIMO: COMPANY SNAPSHOT (2022) 399
11.1.5 FISHER & PAYKEL HEALTHCARE LIMITED 404
TABLE 540 FISHER & PAYKEL HEALTHCARE LIMITED: BUSINESS OVERVIEW 404
FIGURE 51 FISHER & PAYKEL HEALTHCARE LIMITED: COMPANY SNAPSHOT (2022) 405
11.1.6 DRÄGERWERK AG & CO. KGAA 409
TABLE 541 DRÄGERWERK AG & CO. KGAA: BUSINESS OVERVIEW 409
FIGURE 52 DRÄGERWERK AG & CO. KGAA: COMPANY SNAPSHOT (2022) 409
11.1.7 GETINGE 412
TABLE 542 GETINGE: BUSINESS OVERVIEW 412
FIGURE 53 GETINGE: COMPANY SNAPSHOT (2022) 413
11.1.8 NIHON KOHDEN CORPORATION 415
TABLE 543 NIHON KOHDEN CORPORATION: BUSINESS OVERVIEW 415
FIGURE 54 NIHON KOHDEN CORPORATION: COMPANY SNAPSHOT (2022) 415
11.1.9 GE HEALTHCARE 418
TABLE 544 GE HEALTHCARE: BUSINESS OVERVIEW 418
FIGURE 55 GE HEALTHCARE: COMPANY SNAPSHOT (2022) 418
11.1.10 VYAIRE MEDICAL, INC. 420
TABLE 545 VYAIRE MEDICAL, INC.: BUSINESS OVERVIEW 420
11.1.11 BAXTER INTERNATIONAL, INC. 424
TABLE 546 BAXTER INTERNATIONAL, INC.: BUSINESS OVERVIEW 424
FIGURE 56 BAXTER INTERNATIONAL, INC.: COMPANY SNAPSHOT (2022) 425
11.1.12 ADAPTHEALTH, LLC 428
TABLE 547 ADAPTHEALTH, LLC: BUSINESS OVERVIEW 428
FIGURE 57 ADAPTHEALTH, LLC: COMPANY SNAPSHOT (2022) 428
11.1.13 ROTECH HEALTHCARE, INC. 430
TABLE 548 ROTECH HEALTHCARE INC.: BUSINESS OVERVIEW 430
11.1.14 TELEFLEX INCORPORATED 431
TABLE 549 TELEFLEX INCORPORATED: BUSINESS OVERVIEW 431
FIGURE 58 TELEFLEX INCORPORATED: COMPANY SNAPSHOT (2022) 432
11.1.15 AIR LIQUIDE 434
TABLE 550 AIR LIQUIDE: BUSINESS OVERVIEW 434
FIGURE 59 AIR LIQUIDE: COMPANY SNAPSHOT (2022) 435
11.2 OTHER PLAYERS 438
11.2.1 INVACARE CORPORATION 438
TABLE 551 INVACARE CORPORATION: BUSINESS OVERVIEW 438
FIGURE 60 INVACARE CORPORATION: COMPANY SNAPSHOT (2022) 439
11.2.2 ICU MEDICAL 441
TABLE 552 ICU MEDICAL: BUSINESS OVERVIEW 441
FIGURE 61 ICU MEDICAL: COMPANY SNAPSHOT (2022) 442
11.2.3 HAMILTON MEDICAL AG 444
TABLE 553 HAMILTON MEDICAL AG: BUSINESS OVERVIEW 444
11.2.4 APEX MEDICAL CORP 447
TABLE 554 APEX MEDICAL CORP: BUSINESS OVERVIEW 447
11.2.5 MEDLINE INDUSTRIES, LP 449
TABLE 555 MEDLINE INDUSTRIES, LP: BUSINESS OVERVIEW 449
11.2.6 HUM SOCIETY FOR HOMECARE AND MEDICAL TECHNOLOGY MBH 452
TABLE 556 HUM SOCIETY FOR HOMECARE AND MEDICAL TECHNOLOGY MBH: BUSINESS OVERVIEW 452
11.2.7 NONIN 454
11.2.8 ALLIED MEDICAL LLC 455
11.2.9 DRIVE DEVILBISS HEALTHCARE 456
11.2.10 OMRON HEALTHCARE, INC. 457
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
12 APPENDIX 458
12.1 DISCUSSION GUIDE 458
12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 465
12.3 CUSTOMIZATION OPTIONS 467
12.4 RELATED REPORTS 467
12.5 AUTHOR DETAILS 468

★調査レポート[呼吸治療機器のグローバル市場予測(~2028):治療薬、パルスオキシメーター、スパイロメーター] (コード:MD1583-23)販売に関する免責事項を必ずご確認ください。
★調査レポート[呼吸治療機器のグローバル市場予測(~2028):治療薬、パルスオキシメーター、スパイロメーター]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆